Page last updated: 2024-09-02

tadalafil and ciprofloxacin

tadalafil has been researched along with ciprofloxacin in 2 studies

Compound Research Comparison

Studies
(tadalafil)
Trials
(tadalafil)
Recent Studies (post-2010)
(tadalafil)
Studies
(ciprofloxacin)
Trials
(ciprofloxacin)
Recent Studies (post-2010) (ciprofloxacin)
1,7423921,08916,0601,3316,092

Protein Interaction Comparison

ProteinTaxonomytadalafil (IC50)ciprofloxacin (IC50)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)0.41
DNA gyrase subunit BBacillus subtilis subsp. subtilis str. 1686.3
DNA gyrase subunit ABacillus subtilis subsp. subtilis str. 1686.3
Cytochrome P450 3A4Homo sapiens (human)0.31
DNA gyrase subunit BStaphylococcus aureus4.32
DNA gyrase subunit AEscherichia coli K-120.6845
DNA gyrase subunit BEscherichia coli K-120.5632
DNA topoisomerase 4 subunit BStaphylococcus aureus6.485
DNA topoisomerase 4 subunit AStaphylococcus aureus4.8011
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)0.41
DNA gyrase subunit AStaphylococcus aureus4.32
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)0.41
DNA topoisomerase 4 subunit ABacillus subtilis subsp. subtilis str. 1681.7
DNA topoisomerase 4 subunit BBacillus subtilis subsp. subtilis str. 1681.7
GABA theta subunitRattus norvegicus (Norway rat)0.41
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)0.41

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for tadalafil and ciprofloxacin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for tadalafil and ciprofloxacin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013